Ausgabe 10/2016
Inhalt (12 Artikel)
Signaling and molecular basis of bone marrow niche angiogenesis in leukemia
R. Shirzad, S. Shahrabi, A. Ahmadzadeh, K. R. Kampen, M. Shahjahani, N. Saki
Role of taxanes in advanced prostate cancer
J. Cassinello, J. Carballido Rodríguez, L. Antón Aparicio
Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics
L. Moreno, C. Linossi, I. Esteban, N. Gadea, E. Carrasco, S. Bonache, S. Gutiérrez-Enríquez, C. Cruz, O. Díez, J. Balmaña
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse
A. Orlandi, M. A. Calegari, M. Martini, A. Cocomazzi, C. Bagalà, G. Indellicati, V. Zurlo, M. Basso, A. Cassano, L. M. Larocca, C. Barone
Ki-67 is a prognostic marker for hormone receptor positive tumors
M. E. Pérez-López, J. García-Gómez, M. T. Alves, A. Paradela, J. García-Mata, T. García-Caballero
Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study
M. Trovo, N. Giaj-Levra, C. Furlan, M. T. Bortolin, E. Muraro, J. Polesel, E. Minatel, R. Tedeschi, A. R. Filippi, F. Alongi, U. Ricardi
Influence of different treatment techniques and clinical factors over the intrafraction variation on lung stereotactic body radiotherapy
M. Rico, E. Martínez, S. Pellejero, B. Bermejo, P. Navarrete, M. Barrado, M. Campo, F. Mañeru, E. Villafranca, J. Aristu
Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer
Z. Huang, D. Xu, F. Zhang, Y. Ying, L. Song
The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort
A. Gomez-Iturriaga, Á. Cabeza, J. Pastor, J. Jove, M. Casaña, A. G. Caamaño, J. Mengual, I. Henríquez, J. Muñoz, A. Hervás, C. G.-S. Segundo
Long-term visual outcomes in intraocular retinoblastoma with eye preservation
A. Batra, N. Pushker, P. Venkatesh, T. Arora, R. Tewari, S. Bakhshi
Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer
M. Nicoś, P. Krawczyk, B. Jarosz, M. Sawicki, M. Michnar, T. Trojanowski, J. Milanowski
Clinical use of ipilimumab for metastatic melanoma in Spain: towards a more consistent approach
S. Martín-Algarra, L. de la Cruz-Merino, V. Soriano, J. L. Manzano, E. Espinosa